Welcome
NanGenex, member of the DRGT Group, is a druggability enabling NanoActive Technology Company. The company utilizes its integrated technology to provide breakthrough solutions to pharmaceutical and biotech companies in order to develop new generations of drugs with significant performance benefits over conventional approaches.
The technology enables NanGenex to generate proprietary NanoActive Super-APIs by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.
News
Latest Press ReleaseDUBLIN, IRELAND, August 2, 2012 Druggability Technologies Holdings Limited (DRGT) today announced the appointment of Louis Scotti to the newly created position of Chief Business Development Officer. Mr. Scotti will be responsible for all business development activities and managing the company’s numerous existing collaborations for its NanoActiveTM technology platform. Read more |
|
Upcoming events 22-25 April 2013, Chicago, USA 30 April-1 May 2013, San Diego, USA
Latest events 11-13 March 2013, Barcelona, Spain 18 - 20 February 2013, Berlin, Germany 21 - 23 January 2013, Boston, MA, USA 7 - 9 January 2013, San Francisco, CA, USA 28 - 30 November 2012, Boston, MA, USA 12 - 14 November 2012, Hamburg, Germany 14 - 17 October 2012, Toronto, ON, Canada 7-9 October 2012, Brussels, Belgium |